Glaucoma Therapeutic Pipeline Companies and Drugs Review H1 2015 Report at RnRMarketResearch.com
Dallas, TX (PRWEB) January 25, 2015 -- The report "Glaucoma – Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Glaucoma. Glaucoma is caused because of the pressure inside the eye. The primary function of the optic nerve is to send images to the brain. Permanent loss of vision can occur if this optic nerve gets damaged. If not treated on time total permanent blindness might occur. Proper precautions (like visiting an eye doctor) must be taken. The disease can be inherited and if any member of the family is found to be having glaucoma then immediately go for checking. Complete Report is Available @ http://www.rnrmarketresearch.com/glaucoma-pipeline-review-h1-2015-market-report.html .
It also reviews key players involved in the therapeutic development for Glaucoma and special features on late-stage and discontinued projects. Companies discussed in this Glaucoma Pipeline Review H1 2015 report include AC Immune SA, Acadia Pharmaceuticals Inc., Aerie Pharmaceuticals, Inc., Alcon, Inc., Allergan, Inc., Altacor Ltd., Amakem NV, Asahi Kasei Pharma Corp., AUS Bio Limited, Bausch & Lomb Incorporated, Bionure Farma, S.L., Can-Fite BioPharma Ltd., Cellular Biomedicine Group, Inc., China Grand Wuhan General Pharmaceutical Research Institute, D. Western Therapeutics Institute, Inc., DNAVEC Corporation, Dompe Farmaceutici S.p.A., F. Hoffmann-La Roche Ltd., Foamix Pharmaceuticals Ltd., Gene Signal International SA, Gilead Sciences, Inc., Handok Inc., High Point Pharmaceuticals, LLC, Icon Bioscience, Inc., IMMD Inc., Inotek Pharmaceuticals Corporation, InSite Vision Incorporated, Lacer, S.A., Merck & Co., Inc., Merz Pharma GmbH & Co. KgaA, Mimetogen Pharmaceuticals Inc., NeoStem, Inc., Neurotech Pharmaceuticals, Inc., NicOx S.A., Ocata Therapeutics, Inc., Ocular Therapeutix, Inc., Ohr Pharmaceutical Inc., Ono Pharmaceutical Co., Ltd., Otsuka Holdings Co., Ltd., Oxford BioMedica plc, PharmaNova Inc., Quark Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Senju Pharmaceutical Co., Ltd., SIFI S.p.A, SK Biopharmaceuticals Co., Ltd., Sun Pharma Advanced Research Company Ltd., Sylentis S.A., Teva Pharmaceutical Industries Limited, Upsher-Smith Laboratories, Inc.
The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=269510 . (This is a premium report priced at US$2000 for a single user License.)
Table of Contents
List of Tables
Number of Products under Development for Glaucoma, H1 2015
Number of Products under Development for Glaucoma - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Products under Development by Companies, H1 2015 (Contd..2)
Products under Development by Companies, H1 2015 (Contd..3)
Products under Investigation by Universities/Institutes, H1 2015
Glaucoma - Pipeline by AC Immune SA, H1 2015
Glaucoma - Pipeline by Acadia Pharmaceuticals Inc., H1 2015
Glaucoma - Pipeline by Aerie Pharmaceuticals, Inc., H1 2015
Glaucoma - Pipeline by Alcon, Inc., H1 2015
Glaucoma - Pipeline by Allergan, Inc., H1 2015
Glaucoma - Pipeline by Altacor Ltd., H1 2015
Glaucoma - Pipeline by Amakem NV, H1 2015
Glaucoma - Pipeline by Asahi Kasei Pharma Corp., H1 2015
Glaucoma - Pipeline by AUS Bio Limited, H1 2015
Glaucoma - Pipeline by Bausch & Lomb Incorporated, H1 2015
Glaucoma - Pipeline by Bionure Farma, S.L., H1 2015
Glaucoma - Pipeline by Can-Fite BioPharma Ltd., H1 2015
Glaucoma - Pipeline by Cellular Biomedicine Group, Inc., H1 2015
Glaucoma - Pipeline by China Grand Wuhan General Pharmaceutical Research Institute, H1 2015
Glaucoma - Pipeline by D. Western Therapeutics Institute, Inc., H1 2015
Glaucoma - Pipeline by DNAVEC Corporation, H1 2015
Glaucoma - Pipeline by Dompe Farmaceutici S.p.A., H1 2015
Glaucoma - Pipeline by F. Hoffmann-La Roche Ltd., H1 2015
Glaucoma - Pipeline by Foamix Pharmaceuticals Ltd., H1 2015
Glaucoma - Pipeline by Gene Signal International SA, H1 2015
Explore more reports on Ophthalmology therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/ophthalmology-therapeutics .
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Ritesh Tiwari, RnRMarketResearch, http://www.rnrmarketresearch.com/, +1 (888) 391-5441, [email protected]
Share this article